Ghisallo Capital Management’s Entrada Therapeutics TRDA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-15,000	Closed	-$141K	–	293
2022 Q1	$141K	Hold	15,000	–	–	0.02%	285
2021 Q4	$257K	Buy	+15,000	New	+$257K	0.01%	427